Skip to content
Menu

Sight Sciences, Inc. SGHT

Full chart Compare
Set alert

Price alert · SGHT

All alert types
10.62 USD -0.15 (-1.39%)

Regular-session close

10.62 0.00 0.00%

After hours · Nov 19, 4:01 PM ET

10.31 Day range 10.88
3.38 52-week range 11.60
YTD
+33.92%
1 year
+53.25%

5D +0.66 (+6.49%)

10.501111.50MonTueWedThuFri10.83
Market cap
590.25M
Revenue (ttm)
79.54M
Profit margin
-63.30%
EPS (ttm)
-0.52
Shares out
50.40M
Forward P/E
-4.33
YTD return
+33.92%
1-year return
+53.25%
50-day average
4.47
Volume
383.29K
Avg volume
307.11K
Open
10.60
Previous close
10.77
Day's range
10.31 – 10.88
52-week range
3.38 – 11.60
Beta
2.73
Analysts
Hold
Price target
5.02 (-52.7%)

Key statistics

200-day average
5.73
Enterprise value
97.91M
Price / sales
2.22
Price / book
1.86
Revenue growth
0.70%
Free cash flow
-10.15M
Total cash
118.56M
Total debt
35.28M
Return on equity
-45.36%
Short % of float
2.67%

Fundamental scorecard

7 of 25 checks passed on SGHT’s reported financials

ValueGrowthProfitabilityHealthDividend

7of 25 checks passed

  • Value 0 of 5
  • Growth 3 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
SGHT Revenue — quarterly 24.92M
SGHT Net income — quarterly -6.81M
SGHT EPS — quarterly -0.12

Earnings

SGHT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.23-0.22+0.01+4.35%
Aug 1, 2024Jun 1, 2024-0.31-0.25+0.06+19.35%
Aug 1, 2024Jun 1, 2024-0.31———
May 2, 2024Mar 1, 2024-0.29-0.33-0.04-13.79%
May 2, 2024Mar 1, 2024-0.29———
Mar 7, 2024Dec 1, 2023-0.35-0.22+0.13+37.14%

Upgrades / downgrades

SGHT analyst upgrades and downgrades
DateFirmActionFromTo
Dec 11, 2024CitigroupmainNeutralNeutral
Dec 6, 2024UBSinit—Buy
Nov 11, 2024Morgan StanleymainEqual-WeightEqual-Weight
Nov 8, 2024Piper SandlerreitNeutralNeutral
Nov 8, 2024Needhamreit—Hold
Aug 21, 2024Lake Streetinit—Buy

About Sight Sciences, Inc.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on SGHT — it syncs with the Stock Master app.

Insider holders

SGHT insider holders
InsiderRelationLatest transactionDateShares held
BADAWI DAVIDChief Technology OfficerSaleOct 1, 20241,756,480
BADAWI PAULChief Executive OfficerSaleOct 1, 20245,725,430
BAUERLEIN ALISONChief Financial OfficerSaleSep 30, 2024392,555
ENCRANTZ STAFFANDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseNov 20, 20240
HAYDEN JEREMY BRAGGOfficerSaleSep 30, 2024158,687
LINK MATTHEW WOfficerSaleOct 20, 2024663,550

Institution ownership

SGHT institution ownership
Holder% heldSharesValueReported
UBS Group AG4.99%2,532,3238.89MSep 29, 2024
Blackrock Inc.4.41%2,235,7777.85MSep 29, 2024
Bank of America Corporation4.15%2,104,7247.39MSep 29, 2024
Vanguard Group Inc3.33%1,690,7475.93MSep 29, 2024
Jackson Square Partners, Llc1.81%918,0593.22MSep 29, 2024
Long Focus Capital Management, LLC1.70%865,0973.04MSep 29, 2024

Fund ownership

SGHT fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.84%933,7533.28MSep 29, 2024
iShares Russell 2000 ETF1.70%861,8643.03MOct 30, 2024
Vanguard Extended Market Index Fund0.91%459,3351.61MSep 29, 2024
Fidelity Small Cap Index Fund0.71%360,8051.27MAug 30, 2024
iShares Russell 2000 Growth ETF0.60%304,7751.07MOct 30, 2024
Fidelity Extended Market Index Fund0.35%179,036628.42KOct 30, 2024